CN1163129A - Holographic recovery liquid for tumour patient - Google Patents

Holographic recovery liquid for tumour patient Download PDF

Info

Publication number
CN1163129A
CN1163129A CN 96115775 CN96115775A CN1163129A CN 1163129 A CN1163129 A CN 1163129A CN 96115775 CN96115775 CN 96115775 CN 96115775 A CN96115775 A CN 96115775A CN 1163129 A CN1163129 A CN 1163129A
Authority
CN
China
Prior art keywords
radix
rhizoma
holographic
medicine juice
tumour
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 96115775
Other languages
Chinese (zh)
Inventor
刘永
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 96115775 priority Critical patent/CN1163129A/en
Publication of CN1163129A publication Critical patent/CN1163129A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The holographic recovery liquid is prepared with several Chinese medicinal materials including Coix seed, Patrinia scaniosaefolia, Radix asparagi, Sphora subprostrate, sun plant, etc. and through water decoction. It can raise immunity, improve patient's physique and regulate metabolism, and has obvious curative effect to tumour, esp. to middle- and later- stage cance rand no toxic side effect. When combined with holographic tumour curing instrument which introduces medicinal components into tumour, it will result in ever better curative effect.

Description

Holographic recovery liquid for tumour patient
The invention provides a kind of medicine for the treatment of cancer.
Cancer is considered to incurable disease at medical domain so far, and its reason does not have a kind of method for cancer of capturing exactly.The operative treatment patient is painful greatly, expense is high, also the possibility that has recurrence and shift.Chemoluminescence therapy effect is also undesirable, and to middle and terminal cancer, effect is more not obvious.Toxic and side effects of chemoradiotherapy is too big, and gastrointestinal, blood, hair, Liver and kidney are all had overt toxicity, and particularly when heavy dose was used, chemicotherapy had tangible destruction to immune function of human body, makes human body constitution decline, metabolism disorder.Chemicotherapy itself is a kind of carcinogenic factor, and the possibility that causes second tumor is arranged.Because these serious side effects of chemicotherapy, patient can not receive treatment for a long time, thereby has reduced curative effect.
The purpose of this invention is to provide a kind of holographic recovery liquid for tumour patient, to improve the oncotherapy effect, the serious side effects of avoiding the chemicotherapy method to produce.
The present invention realizes like this, this healing liquid is by a, with the Chinese herbal medicine is raw material, its compatibility is Semen Coicis 30~50g, Herba Patriniae 20~30g, Radix Asparagi 20~30g, Radix Sophorae Tonkinensis 20~30g, Herba Scutellariae Barbatae 30g, Rhizoma Coptidis 3~6g, Semen Armeniacae Amarum 20~30g, Bulbus Iphigeniae Indicae 5g, 1 of Scolopendra, Caulis et Folium Crotalariae Assamicae 5~6g, Rhizoma Dioscoreae Bulbiferae 20~30g, Rhizoma Smilacis Chinensis 10~15g, Radix Arnebiae (Radix Lithospermi) 10~20g, 1 of dry maxima skin, Herba Solani Nigri 20~30g, Pseudobulbus cremastrae seu pleiones 6~10g, Herba Andrographis 10-15g, 1~2 of the speckle insect destructive of the roots of seedlings, Fructus Bruceae 6~10g, Rhizoma Arisaematis 2~3g, Rhizoma Curcumae 10~15g, Radix Trichosanthis 10~12g, Semen Euphorbiae 1g, Pericarpium Trichosanthis 6g
B, above-mentioned raw materials is added 500~800 milliliters in cold water, soak after 1~1.5 hour, boil with very hot oven, fried in shallow oil after boiling 0.5~1 hour, fry in shallow oil to the medicine juice amount be 220~270 milliliters, take out medicine juice, add 500~800 milliliters in cold water again and use and fry in shallow oil second with quadrat method and close, with fry in shallow oil 220~270 milliliter second close medicine juice and pour out, with two close the medicine juice mix homogeneously and make.
This recovery liquid for tumour patient therapeutic effect is good, and is especially obvious to treatment middle and advanced stage patient effect, treats a large amount of patients with this healing liquid, do not see obvious toxic-side effects.As in conjunction with holographic tumor recovering instrument, can directly pharmaceutical compositions be imported in the tumor body, therapeutic effect is better.This healing liquid can improve body immunity, adjusts metabolism.Because its safety non-toxic, but life-time service.
The embodiment that below provides the holographic recovery liquid for tumour patient that utilizes the present invention to treat.
Embodiment 1: cattle * *, man, 18 years old.Dizziness on November 2 in 1998, the puffiness of the eyes, weak, the bone marrow aspiration inspection turns out to be leukemia.Course of treatment of chemotherapy, sb.'s illness took a turn for the worse, and December in 1988 changeed this punishment on the 6th and treats.Giving holographic recovery liquid for tumour patient treats on February 23rd, 1989 in conjunction with holographic tumor recovering instrument.Look into T36.5 ℃, do not have discomfort, Hb13.7%, B1%, L38%, M1%, the bone marrow aspiration check: obvious proliferation, G: E=1.83: 1, grain is that hypertrophy is good, early following each phase sees that all the ratio form is roughly normal, and red is active proliferation, each phase all sees, the ratio form is normal, and lymphatic system is normal, and full sheet is seen 38 of megalokaryocytes, platelet sees that acute leukemia is alleviated fully more.
Embodiment 2: Cui * *, the man, 60 years old, be diagnosed as gastric cancer on June 13rd, 1991, operation carry out total gastrectomy after 40 days B ultrasonic turn out to be the head of pancreas metastatic carcinoma, tumor body 2.4 * 4cm, on July 24th, 1991 is to this punishment treatment.Giving holographic recovery liquid for tumour patient treats on August 26th, 1991, transference cure in conjunction with holographic tumor recovering instrument.Ultrasound diagnosis: liver do not visit and unusually, gallbladder tension is slightly high, the gallbladder wall thickness is crude, bile duct is normal, does not visit and be obviously unusual in the pancreas district, clinical cure.
Embodiment 3: Lee * *, the woman, 19 years old, on March 2nd, 1989 was suffered from acute abdominal pain, and being admitted to hospital is diagnosed as the ovary endodermal sinus tumor, with chemotherapy behind the tumor body excision once.On March 22nd, 1989 was treated to this punishment.Giving holographic recovery liquid for tumour patient treats in conjunction with holographic instrument, carried out ultrasound diagnosis in every month, all normal, the last ultrasound diagnosis in June 4 nineteen ninety shows: anteversion of uterus, and palace body size is 5 * 3.1 * 4cm, inner membrance is clear, flesh layer echo is even, and right side members is normal, and left side attachment shows unclear, so far not recurrence is cured.

Claims (1)

  1. Holographic recovery liquid for tumour patient, it is characterized in that, described healing liquid is by a, with the Chinese herbal medicine is raw material, its compatibility is, Semen Coicis 30~509, Herba Patriniae 20~30g, Radix Asparagi 20~30g, Radix Sophorae Tonkinensis 20~30g, Herba Scutellariae Barbatae 30g, Rhizoma Coptidis 3~6g, Semen Armeniacae Amarum 20~30g, Bulbus Iphigeniae Indicae 5g, 1 of Scolopendra, Caulis et Folium Crotalariae Assamicae 5~6g, Rhizoma Dioscoreae Bulbiferae 20~30g, Rhizoma Smilacis Chinensis 10~15g, Radix Arnebiae (Radix Lithospermi) 10~20g, 1 of dry maxima skin, Herba Solani Nigri 20~30g, Pseudobulbus cremastrae seu pleiones 6~10g, Herba Andrographis 10-15g, 1~2 of the speckle insect destructive of the roots of seedlings, Fructus Bruceae 6~10g, Rhizoma Arisaematis 2~3g, Rhizoma Curcumae 10~15g, Radix Trichosanthis 10~12g, Semen Euphorbiae 1g, Pericarpium Trichosanthis 6g
    B, above-mentioned raw materials is added 500~800 milliliters in cold water, soak after 1~1.5 hour, boil with very hot oven, fried in shallow oil after boiling 0.5~1 hour, fry in shallow oil to the medicine juice amount be 220~270 milliliters, take out medicine juice, add cold water again and use and fry in shallow oil second with quadrat method and close, close medicine juice with 220~270 milliliter second and take out, close the medicine juice mix homogeneously with two and make.
CN 96115775 1996-04-25 1996-04-25 Holographic recovery liquid for tumour patient Pending CN1163129A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 96115775 CN1163129A (en) 1996-04-25 1996-04-25 Holographic recovery liquid for tumour patient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 96115775 CN1163129A (en) 1996-04-25 1996-04-25 Holographic recovery liquid for tumour patient

Publications (1)

Publication Number Publication Date
CN1163129A true CN1163129A (en) 1997-10-29

Family

ID=5122993

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 96115775 Pending CN1163129A (en) 1996-04-25 1996-04-25 Holographic recovery liquid for tumour patient

Country Status (1)

Country Link
CN (1) CN1163129A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569234B2 (en) * 2003-12-19 2009-08-04 Ming Qi Oncology Chinese Medicines, Inc. Herb composition for treating lung cancer and preparation method thereof
CN103705897A (en) * 2014-01-03 2014-04-09 陈延玲 Cancer pain-relieving plaster
CN108498711A (en) * 2018-05-24 2018-09-07 宋建美 It is a kind of to import the Chinese medicine composition that tumour is treated in tumor area by targeting

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7569234B2 (en) * 2003-12-19 2009-08-04 Ming Qi Oncology Chinese Medicines, Inc. Herb composition for treating lung cancer and preparation method thereof
CN103705897A (en) * 2014-01-03 2014-04-09 陈延玲 Cancer pain-relieving plaster
CN103705897B (en) * 2014-01-03 2016-04-13 陈延玲 A kind of cancer relieves the pain plaster
CN108498711A (en) * 2018-05-24 2018-09-07 宋建美 It is a kind of to import the Chinese medicine composition that tumour is treated in tumor area by targeting

Similar Documents

Publication Publication Date Title
CN100421724C (en) Traditional medicine composition for treating chronic colitis and its preparing process
CN105582414A (en) Traditional Chinese medicine composition for improving immunologic function of piglets and preparation method thereof
CN103860699B (en) A kind of pharmaceutical composition for effecting a radical cure three-hypers
CN101518600B (en) Chinese medicinal composition for treating bacterial or fungal dermatosis and preparation method thereof
CN101569739B (en) Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof
CN102824445B (en) Traditional Chinese medicine composition for treating duodenal ulcer
CN102552608B (en) Medicine composition used for treating fracture and bone injury, preparation method thereof, and purpose thereof
CN101804175B (en) Anti-cancer Chinese medicinal powder and preparation method thereof
CN1163129A (en) Holographic recovery liquid for tumour patient
CN102727830A (en) Traditional Chinese medicine calculus removing capsules
CN105878933A (en) Traditional Chinese medicine composition for treating gastrectasia
CN1060078C (en) Chinese herbal medicine composition for curing malignant lymphoma
CN102205109B (en) Chinese medicinal composition for treating rheumatism and application thereof
CN104257986A (en) Traditional Chinese medicine for treating nephritis
CN1079252C (en) Compound graceful jassamine preparation
CN104940752A (en) Chinese medicine preparation for treating vulva ulcer and preparing method thereof
CN1085439A (en) A kind of anticancer herbal drug
CN104825598A (en) External-use plaster for treating rheumatic bone pain and preparation method thereof
CN104001100A (en) Traditional Chinese medicine composition for treating PICC (Peripherally Inserted Central Catheter) phlebothrombosis and preparation method of traditional Chinese medicine composition
CN102626491B (en) Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion
CN102423369B (en) Chinese medicinal composition for preventing or treating ovarian cancer
CN103356959B (en) Pharmaceutical composition for treating hyperplasia of mammary glands
CN106237101A (en) A kind of Chinese medicine formula treating breast carcinoma
CN1052909C (en) Hyperosteogeny curing medicine
CN104721740A (en) Traditional Chinese medicine composition for treating lymphatic tuberculosis and lymphoma

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1042406

Country of ref document: HK